Open AccessDynamic changes in intrinsic subtype, immunity status, and risk score before and after neoadjuvant chemo- and HER2-targeted therapy without pCR in HER2-positive breast cancers: A cross-sectional analysis
Author(s) -
Peixian Chen,
Xiaofan Mao,
Na Ma,
Chuan Wang,
Guangyu Yao,
Guolin Ye,
Dan Zhou
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000029877
Subject(s) - medicine , oncology , breast cancer , trastuzumab , immunity , subgroup analysis , neoadjuvant therapy , adjuvant , cancer , confidence interval , immune system , immunology